Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.

<h4>Background</h4>Multiple sclerosis (MS) is a complex neurological disorder marked by neuroinflammation and demyelination. Understanding its molecular basis is vital for developing effective treatments. This study aims to elucidate the molecular progression of MS using multiomics and n...

Full description

Saved in:
Bibliographic Details
Main Authors: Nitesh Shriwash, Ayesha Aiman, Prithvi Singh, Seemi Farhat Basir, Anas Shamsi, Mohammad Shahid, Ravins Dohare, Asimul Islam
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0314428
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555440174891008
author Nitesh Shriwash
Ayesha Aiman
Prithvi Singh
Seemi Farhat Basir
Anas Shamsi
Mohammad Shahid
Ravins Dohare
Asimul Islam
author_facet Nitesh Shriwash
Ayesha Aiman
Prithvi Singh
Seemi Farhat Basir
Anas Shamsi
Mohammad Shahid
Ravins Dohare
Asimul Islam
author_sort Nitesh Shriwash
collection DOAJ
description <h4>Background</h4>Multiple sclerosis (MS) is a complex neurological disorder marked by neuroinflammation and demyelination. Understanding its molecular basis is vital for developing effective treatments. This study aims to elucidate the molecular progression of MS using multiomics and network-based approach.<h4>Methods</h4>We procured differentially expressed genes in MS patients and healthy controls by accessing mRNA dataset from a publicly accessible database. The DEGs were subjected to a non-trait weighted gene co-expression network (WGCN) for hub DEGs identification. These hub DEGs were utilized for enrichment, protein-protein interaction network (PPIN), and feed-forward loop (FFL) analyses.<h4>Results</h4>We identified 880 MS-associated DEGs. WGCN revealed a total of 122 hub DEGs of which most significant pathway, gene ontology (GO)-biological process (BP), GO-molecular function (MF) and GO-cellular compartment (CC) terms were assembly and cell surface presentation of N-methyl-D-aspartate (NMDA) receptors, regulation of catabolic process, NAD(P)H oxidase H2O2 forming activity, postsynaptic recycling endosome. The intersection of top 10 significant pathways, GO-BP, GO-MF, GO-CC terms, and PPIN top cluster genests identified STAT3 and CREB1 as key biomarkers. Based on essential centrality measures, CREB1 was retained as the final biomarker. Highest-order subnetwork FFL motif comprised one TF (KLF7), one miRNA (miR-328-3p), and one mRNA (CREB1) based on essential centrality measures.<h4>Conclusions</h4>This study provides insights into the roles of potential biomarkers in MS progression and offers a system-level view of its molecular landscape. Further experimental validation is needed to confirm these biomarkers' significance, which will lead to early diagnostic and therapeutic advancements.
format Article
id doaj-art-27ebbe0811b045b3ba15c7420b20d54b
institution Kabale University
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-27ebbe0811b045b3ba15c7420b20d54b2025-01-08T05:32:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031442810.1371/journal.pone.0314428Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.Nitesh ShriwashAyesha AimanPrithvi SinghSeemi Farhat BasirAnas ShamsiMohammad ShahidRavins DohareAsimul Islam<h4>Background</h4>Multiple sclerosis (MS) is a complex neurological disorder marked by neuroinflammation and demyelination. Understanding its molecular basis is vital for developing effective treatments. This study aims to elucidate the molecular progression of MS using multiomics and network-based approach.<h4>Methods</h4>We procured differentially expressed genes in MS patients and healthy controls by accessing mRNA dataset from a publicly accessible database. The DEGs were subjected to a non-trait weighted gene co-expression network (WGCN) for hub DEGs identification. These hub DEGs were utilized for enrichment, protein-protein interaction network (PPIN), and feed-forward loop (FFL) analyses.<h4>Results</h4>We identified 880 MS-associated DEGs. WGCN revealed a total of 122 hub DEGs of which most significant pathway, gene ontology (GO)-biological process (BP), GO-molecular function (MF) and GO-cellular compartment (CC) terms were assembly and cell surface presentation of N-methyl-D-aspartate (NMDA) receptors, regulation of catabolic process, NAD(P)H oxidase H2O2 forming activity, postsynaptic recycling endosome. The intersection of top 10 significant pathways, GO-BP, GO-MF, GO-CC terms, and PPIN top cluster genests identified STAT3 and CREB1 as key biomarkers. Based on essential centrality measures, CREB1 was retained as the final biomarker. Highest-order subnetwork FFL motif comprised one TF (KLF7), one miRNA (miR-328-3p), and one mRNA (CREB1) based on essential centrality measures.<h4>Conclusions</h4>This study provides insights into the roles of potential biomarkers in MS progression and offers a system-level view of its molecular landscape. Further experimental validation is needed to confirm these biomarkers' significance, which will lead to early diagnostic and therapeutic advancements.https://doi.org/10.1371/journal.pone.0314428
spellingShingle Nitesh Shriwash
Ayesha Aiman
Prithvi Singh
Seemi Farhat Basir
Anas Shamsi
Mohammad Shahid
Ravins Dohare
Asimul Islam
Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
PLoS ONE
title Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
title_full Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
title_fullStr Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
title_full_unstemmed Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
title_short Understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
title_sort understanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network based approach
url https://doi.org/10.1371/journal.pone.0314428
work_keys_str_mv AT niteshshriwash understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach
AT ayeshaaiman understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach
AT prithvisingh understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach
AT seemifarhatbasir understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach
AT anasshamsi understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach
AT mohammadshahid understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach
AT ravinsdohare understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach
AT asimulislam understandingtheroleofpotentialbiomarkersinattenuatingmultiplesclerosisprogressionviamultiomicsandnetworkbasedapproach